,23-interleukin

Tamara Kopp1, Elisabeth Riedl2, Christine Bangert3

  • 11] Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases, University of Vienna Medical School, 1090 Vienna, Austria [2] Juvenis Medical Center, 1010 Vienna, Austria.

Nature
|March 11, 2015
PubMed
概括

针对牛皮的向治疗方法Tildrakizumab在I期研究中有效降低了疾病的严重程度. 这种联素-23p19抑制剂在中度至重度牛皮的患者中显示出显著的临床改善.